%D8%A5%D8%AE%D8%AA%D9%84%D8%A7%D9%84_%D8%A7%D9%84%D9%85%D9%8A%D9%83%D8%B1%D9%88%D8%A8%D9%8A%D9%88%D9%85DysbioseDysbiosisDisbiosisD%C3%BCsbioosDisbiosi%D9%86%D8%A7%D8%AA%D8%B1%D8%A7%D8%B2%D8%B4%D8%AF%D9%86_%D9%87%D9%85%D8%B2%DB%8C%D8%B3%D8%AA%DB%8CDysbioseDiosb%C3%B3isDiszbi%C3%B3zisDisbiosiDisbioseQ269334
about
The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal MicrobiotaThe First Line of Defense: The Effects of Alcohol on Post-Burn Intestinal Barrier, Immune Cells, and MicrobiomeProtective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017.Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and ImmunityKetamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory propertiesBacterial Dysbiosis and Translocation in Psoriasis VulgarisFecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcomeThe Role of Succinate in the Regulation of Intestinal InflammationPreventive Medicine for Person, Place, and Planet: Revisiting the Concept of High-Level Wellness in the Planetary Health ParadigmIdentification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut DysbiosisThe Neonatal Microbiome and Its Partial Role in Mediating the Association between Birth by Cesarean Section and Adverse Pediatric OutcomesFaecal Analyses in Rheumatoid Arthritis TherapyNatural History of Intestinal Inflammation in People With Primary Immune DysregulationsFecal Microbiota Transplant for Primary CDIThe Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients.Lactobacillus Reuteri DSM 17938 in Gut Microbiota Development in Infant Born by Caesarean SectionThe microbiome and immunodeficiencies: Lessons from rare diseasesGlutamatergic Signaling Along The Microbiota-Gut-Brain AxisExposure of the Host-Associated Microbiome to Nutrient-Rich Conditions May Lead to Dysbiosis and Disease Development-an Evolutionary PerspectiveFunctional dysbiosis within dental plaque microbiota in cleft lip and palate patientsHaem iron reshapes colonic luminal environment: impact on mucosal homeostasis and microbiome through aldehyde formationCNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy VolunteersDecreased Protein Kinase C-β Type II Associated with the Prominent Endotoxin Exhaustion in the Macrophage of FcGRIIb-/- Lupus Prone Mice is Revealed by Phosphoproteomic AnalysisFecal metatranscriptomics of macaques with idiopathic chronic diarrhea reveals altered mucin degradation and fucose utilizationCharacterization of Microbiota Associated with Digesta and Mucosa in Different Regions of Gastrointestinal Tract of Nursery PigsCould the menagerie of the gut microbiome really cure cancer? Hope or hypeEmerging trends and research foci in gastrointestinal microbiomeAltered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV InfectionShort Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel DiseasesDiet-Related Metabolic Perturbations of Gut Microbial Shikimate Pathway-Tryptamine-tRNA Aminoacylation-Protein Synthesis in Human Health and DiseaseInteractions between a pathogenic Blastocystis subtype and gut microbiota: in vitro and in vivo studiesInfection in Chronic Inflammation and Gastrointestinal CancerAltered Bacterial-Fungal Interkingdom Networks in the Guts of Ankylosing Spondylitis PatientsAllergy as a Disease of Dysbiosis: Is It Time to Shift the Treatment Paradigm?In Vitro Antimicrobial Activity and Probiotic Potential of and against Species ofDysbiosis of the Gut Microbiota on the Inflammatory Background due to Lack of Suppressor of Cytokine Signalling-1 in MiceCrosstalk Between the Microbiome and Gestational Immunity in Autism-Related DisordersImpact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Diseaseenterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities
P921
Q26773227-ae1dc304-4842-519e-ecdd-84edf82c8a27Q26773231-37aeee95-4808-9674-b077-a4f186d45b4cQ46454159-E380AC84-78BD-4266-B0AC-D29D0E51E836Q54965289-0E51474D-7E5C-4106-A49C-AF7DC51A280BQ60046972-4CB9151B-9CF7-49C6-8F57-21986C2E02EAQ60935997-9DB5241B-9A3B-437D-9747-9D360D9D6074Q61799988-35A1E031-DC26-453B-AF32-EBD2154FFDA4Q61804908-FDE5C067-33B3-4F2F-95D4-0E3D1DCCBBCBQ61814405-10592E36-00E2-438B-B35C-ED0F60C4FA93Q61815040-281B3B70-663C-4C03-964F-DEAB1FA69C5BQ61815436-B3C64611-B33E-4747-8E9C-2254F94A2DDCQ61837805-E1CE5ADD-C403-4690-A695-EBF2E9EA6093Q62030863-53983BAB-3A3B-4C81-BADE-1AD9DDB3AB3BQ63575562-E12336B8-8EFB-446B-93C4-48EFC7E79CAFQ63593167-6843A49C-C39B-476F-A905-E2E9CF145A61Q63597095-D77ED100-0DA1-4D62-98E4-B5FC7F06AD08Q63597316-CE86CB2E-6FC9-4806-8208-FAC8A2B1A241Q64040933-1E3B5CE9-DD65-48BE-A5E8-24D0C23EF613Q64055380-B4099B52-8819-41FA-B7C4-7849F09EB7DEQ64056378-14D4CC8B-6B8F-4AB7-BE83-5DF96B982C48Q64056840-FA020C72-2ACE-4603-B407-844B85F3FDD1Q64065714-DD7B1084-CB8D-4B4A-97A3-560F8C800E29Q64067716-741744A4-B46A-4F1E-9E2E-67BAD5172914Q64080189-F138A31C-CCE9-4993-B299-06AB0D47060BQ64081386-A84D6A32-7B73-483F-B1C3-A885D2EF15BEQ64085467-F6D7BD79-2C43-4210-B897-4AAFBEC86E0FQ64085687-DFD57B18-0939-47CD-9091-ADBCE0D0D78FQ64089801-F91FA314-0160-43FD-92B0-22D61B279E81Q64102276-B7572720-A3AE-4414-9C8D-FC04D562E06EQ64107231-97656D23-79F3-44DE-BD3C-C0016FCA39F4Q64107610-CF1E4593-0AA6-4482-8088-5AB055287A02Q64108477-C7B9BBBC-F78C-4F8E-916B-15C406B0E92DQ64110671-E1BE6CC3-C476-4DAC-B22D-FF2B4FFDF1C9Q64120380-65F06B14-7430-4588-95F2-86620BF59902Q64120664-4A27D232-82FA-4C17-B7CE-0C07BAFD94E7Q64120855-AB4BEAB9-FBDE-4699-BFFC-CBE4F305E540Q64128808-DCF4BFD8-38F6-4026-BAD6-32133C05B27EQ64225611-7E992512-3E2E-4D5E-A584-B652E9C4FD63Q64232494-423F6E2C-D7CB-4554-B3E6-4416A38BE342Q64235113-4B50D578-CB00-4CEA-9ABA-43DA3F06E823
P921
description
changes in microbiota leading to disease
@en
medical condition
@en-ca
état de santé
@fr
تغییرات میکروبیوت که منجر به بیماری شود
@fa
name
Diosbóis
@ga
Disbakteriozė
@lt
Disbatteriosi
@it
Disbiose
@pt
Disbiosi
@eu
Disbiosis
@es
Diszbiózis
@hu
Dysbiose
@de
Dysbiosis
@en-ca
Düsbioos
@et
type
label
Diosbóis
@ga
Disbakteriozė
@lt
Disbatteriosi
@it
Disbiose
@pt
Disbiosi
@eu
Disbiosis
@es
Diszbiózis
@hu
Dysbiose
@de
Dysbiosis
@en-ca
Düsbioos
@et
altLabel
Dysbiose
@fr
prefLabel
Diosbóis
@ga
Disbakteriozė
@lt
Disbatteriosi
@it
Disbiose
@pt
Disbiosi
@eu
Disbiosis
@es
Diszbiózis
@hu
Dysbiose
@de
Dysbiosis
@en-ca
Düsbioos
@et
P486
P6366
P646
P672
P3417
P486
P6366
2777165150
P646
P672
C23.550.308